These mechanisms support the hypothesis that Pg-induced periapical lesions contribute to systemic metabolic diseases via these immuno-inflammatory pathways.27–29 We investigated whether IL-17 could acts as a molecular mediator linking Pg-induced periapical lesions to systemic metabolic dysfunction. The gene discussed is IL17A; the disease is metabolic disease.